Anthony Curtis
Anthony Curtis
School of Pharmacy, Keele University
Bestätigte E-Mail-Adresse bei keele.ac.uk
Titel
Zitiert von
Zitiert von
Jahr
Comprehensive heterocyclic chemistry III
B Wrackmeyer, OL Tok, AR Katritzky, CA Ramsden, EFV Scriven, ...
Elsevier: Oxford, 1181-1223, 2008
191*2008
Structure correction and synthesis of the naturally occurring benzothiazinone BMY 40662
TR Kelly, MH Kim, ADM Curtis
The Journal of Organic Chemistry 58 (21), 5855-5857, 1993
771993
Application of nanoparticle technologies in the combat against anti-microbial resistance
M Kumar, A Curtis, C Hoskins
Pharmaceutics 10 (1), 11, 2018
542018
Preclinical evaluation of statins as a treatment for ovarian cancer
E Robinson, M Nandi, LL Wilkinson, DM Arrowsmith, ADM Curtis, ...
Gynecologic oncology 129 (2), 417-424, 2013
412013
1, 2, 4‐Triazoles
ADM Curtis
ChemInform 36 (11), no-no, 2005
382005
Novel calix [4] resorcinarene glycosides
ADM Curtis
Tetrahedron letters 38 (24), 4295-4296, 1997
381997
The use of iron oxide nanoparticles for pancreatic cancer therapy
M Malekigorji, ADM Curtis, C Hoskins
Journal of Nanomedicine Research 1 (1), 2014
342014
Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy
V Khare, WA Sakarchi, PN Gupta, ADM Curtis, C Hoskins
RSC advances 6 (65), 60126-60137, 2016
312016
Interaction of a water soluble fullerene derivative with reactive oxygen species and model enzymatic systems
S Foley, ADM Curtis, A Hirsch, M Brettreich, A Pelegrin, P Seta, ...
Fullerenes, Nanotubes and Carbon Nanostructures 10 (1), 49-67, 2002
252002
Asymmetric Diels-Alder reactions. VI: Regio-and stereo-selective cycloadditions of 5-(2', 3', 4', 6'-tetra-O-acetyl-β-D-glucopyranosyloxy)-1, 4-naphthoquinone
B Beagley, ADM CURTIS, RG Pritchard, RJ Stoodley
Journal of the Chemical Society. Perkin transactions. I, 1981-1991, 1992
241992
Nanotechnologies in pancreatic cancer therapy
A Manzur, A Oluwasanmi, D Moss, A Curtis, C Hoskins
Pharmaceutics 9 (4), 39, 2017
232017
Thermally triggered theranostics for pancreatic cancer therapy
M Malekigorji, M Alfahad, PKT Lin, S Jones, A Curtis, C Hoskins
Nanoscale 9 (34), 12735-12745, 2017
202017
The use of nanotechnology in cardiovascular disease
M Chandarana, A Curtis, C Hoskins
Applied Nanoscience 8 (7), 1607-1619, 2018
192018
Stereoselective aldol reactions of β-boronate carbonyl derivatives.
ADM Curtis, A Whiting
Tetrahedron letters 32 (11), 1507-1510, 1991
191991
Diels Alder-mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy
A Oluwasanmi, W Al-Shakarchi, A Manzur, MH Aldebasi, RS Elsini, ...
Journal of Controlled Release 266, 355-364, 2017
172017
The Synthesis of C2-Symmetric and Axially Chiral Compounds for Recognition and Catalysis
J Clews, ADM Curtis, H Malkin
Tetrahedron 56 (44), 8735-8746, 2000
172000
The origin of the stereoselectivity in the aldol reactions of β-boronate carbonyl derivatives.
ADM Curtis, RJ Mears, A Whiting
Tetrahedron 49 (1), 187-198, 1993
171993
Stimuli responsive polymeric systems for cancer therapy
A Alsuraifi, A Curtis, DA Lamprou, C Hoskins
Pharmaceutics 10 (3), 136, 2018
152018
Heat dissipation of hybrid iron oxide-gold nanoparticles in an agar phantom
ADM Curtis, M Malekigorji, J Holman, MA Skidmore, C Hoskins
Journal of Nanomedicine and Nanotechnology 6 (6), 2015
132015
Simple calix [n] arenes and calix [4] resorcinarenes as drug solubilizing agents
C Hoskins, ADM Curtis
Journal of Nanomedicine Research 2 (3), 2015
132015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20